ReCor Medical

Acquired

Transforming hypertension management through ultrasound renal denervation

ReCor Medical was founded in 2009, is headquartered in Palo Alto, United States, lists 201–500 employees, and has $25.4M in recorded funding across 2 rounds.

Employees
201–500
Founded
2009
Business Model
B2B
Total Funding
$25.4M
Last Round
$15.0M Series DJun 2017
Rounds
2
Acquisition Date
Jul 2018

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Recor Medical is a medical technology company focused on transforming the management of hypertension through its FDA-approved Paradise Ultrasound Renal Denervation (uRDN) system. The Paradise system uses 360-degree ultrasound energy to ablate renal nerves in 7-second treatment cycles, delivering clinically proven blood pressure reductions sustained across multiple years in patients with uncontrolled or resistant hypertension. As a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., Recor sells to interventional cardiologists and hospital catheterization labs in the United States and internationally, where the system also bears CE mark approval. The company has conducted multiple successful U.S. randomized controlled trials (RADIANCE-HTN series) and obtained a CMS National Coverage Determination, establishing a reimbursement pathway for routine clinical adoption.

Summary

ReCor Medical is a Healthcare company based in Palo Alto, United States, founded in 2009. It lists 201–500 employees. It has raised $25.4M in total across 2 rounds, most recently a $15.0M Series D round in Jun 2017. Investors include Otsuka Holdings and Sofinnova Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionJul 2018

Sign up to see all 3 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ReCor Medical on Indexed.vc
<a href="https://indexed.vc/companies/recor-medical"><img src="https://indexed.vc/api/badge/company/recor-medical" alt="ReCor Medical on Indexed.vc" width="260" height="76" /></a>